Effect of dosage failed of first antiepileptic drug on subsequent outcome

Epilepsia

Volumn 54, Issue 1, 2013, Pages 194-198

  Brodie, Martin J ^a   Barry, Sarah J E ^b   Bamagous, Ghazi A ^a   Kwan, Patrick ^c,d,e  

^a WESTERN INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Antiepileptic drug; Dose; Drug resistance; Epilepsy; Seizure freedom

Indexed keywords

ANTICONVULSIVE AGENT;

ANTICONVULSANT THERAPY; ARTICLE; DISEASE COURSE; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG TREATMENT FAILURE; EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; CHILD; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; ROC CURVE; TREATMENT FAILURE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872087244     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03722.x     Document Type: Article

References (18)

1. Albani F, Grassi B, Ferrara R, Turrini R, Baruzzi A,; PRIMO Study Group. (2004) Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. Seizure 13: 254-263.
2. Berg AT,. (2009) Identification of pharmacoresistant epilepsy. Neurol Clin 27: 1003-1013.
3. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ,; for the Levetiracetam Monotherapy Study Group. (2007) Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 68: 402-408.
4. Brodie MJ, Barry SJE, Bamagous GA, Norrie JD, Kwan P,. (2012) Patterns of treatment response in newly diagnosed epilepsy. Neurology 78: 1548-1554.
5. Canevini MP, De Sarro G, Galimberti CA, Gatti G, Licchetta L, Malerba A, Muscas G, La Neve A, Striano P, Perucca E,; on behalf of the SOPHIE Study Group. (2010) Relationship between adverse effects of antiepileptic drugs, number of co-prescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia 51: 797-804.
6. Chan AL, Wang MT, Su CY, Tsai FH,. (2009) Risk of digoxin intoxication caused by clarithromycin-digoxin interactions in heart failure patients: a population-based study. Eur J Clin Pharmacol 65: 1237-1243.
7. De Bruin ML, Langendijk PN, Koopmans RP, Wilde AA, Leufkens HG, Hoes AW,. (2007) In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs. Br J Clin Pharmacol 63: 216-223.
8. Deckers CL, Hekster YA, Keyser A, Meinardi H, Renier WO,. (1997) Reappraisal of polytherapy in epilepsy: a critical review of drug load and adverse effects. Epilepsia 38: 570-575.
9. Dlugos DJ, Sammel MD, Strom BL, Farrar JT,. (2001) Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology 57: 2259-2264.
10. Gray RJ,. (1988) A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16: 1141-1154.
11. Kwan P, Brodie MJ,. (2000) Early identification of refractory epilepsy. N Engl J Med 342: 314-319.
12. Kwan P, Brodie MJ,. (2001) Effectiveness of first antiepileptic drug. Epilepsia 42: 1255-1260.
13. Kwan P, Brodie MJ,. (2010) Definition of refractory epilepsy: defining the indefinable? Lancet Neurol 9: 27-29.
14. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Hauser WA, Mathern G, Moshé SL, Perucca E, Wiebe S, French J,. (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51: 1069-1077.
15. Kwan P, Schachter SC, Brodie MJ,. (2011) Drug-resistant epilepsy. N Engl J Med 369: 919-926.
16. Perucca E, Dulac O, Shorvon S, Tomson T,. (2001) Harnessing the clinical potential of antiepileptic drug therapy: dosage optimisation. CNS Drugs 15: 609-621.
17. R Development Core Team. (2011) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, Available at: http://www.R-project.org/.
18. WHO Collaborating Centre for Drug Statistics Methodology. (2011) ATC/DDD Index. Available at: http://www.whocc.no/atc-ddd-index/ (Accessed November 1, 2011).